These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 19380809
1. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. Garaud S, Le Dantec C, Jousse-Joulin S, Hanrotel-Saliou C, Saraux A, Mageed RA, Youinou P, Renaudineau Y. J Immunol; 2009 May 01; 182(9):5623-32. PubMed ID: 19380809 [Abstract] [Full Text] [Related]
2. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus. Hillion S, Garaud S, Devauchelle V, Bordron A, Berthou C, Youinou P, Jamin C. Immunology; 2007 Nov 01; 122(3):371-80. PubMed ID: 17608810 [Abstract] [Full Text] [Related]
3. The paradox of CD5-expressing B cells in systemic lupus erythematosus. Youinou P, Renaudineau Y. Autoimmun Rev; 2007 Dec 01; 7(2):149-54. PubMed ID: 18035326 [Abstract] [Full Text] [Related]
4. High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus. Huck S, Jamin C, Youinou P, Zouali M. J Autoimmun; 1998 Oct 01; 11(5):449-55. PubMed ID: 9802928 [Abstract] [Full Text] [Related]
5. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Mi XB, Zeng FQ. Acta Pharmacol Sin; 2008 Jan 01; 29(1):105-12. PubMed ID: 18158872 [Abstract] [Full Text] [Related]
6. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. Hagn M, Ebel V, Sontheimer K, Schwesinger E, Lunov O, Beyer T, Fabricius D, Barth TF, Viardot A, Stilgenbauer S, Hepp J, Scharffetter-Kochanek K, Simmet T, Jahrsdörfer B. Eur J Immunol; 2010 Jul 01; 40(7):2060-9. PubMed ID: 20394077 [Abstract] [Full Text] [Related]
7. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Li Y, Zhao M, Yin H, Gao F, Wu X, Luo Y, Zhao S, Zhang X, Su Y, Hu N, Long H, Richardson B, Lu Q. Arthritis Rheum; 2010 May 01; 62(5):1438-47. PubMed ID: 20131288 [Abstract] [Full Text] [Related]
8. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. Díaz-Alderete A, Crispin JC, Vargas-Rojas MI, Alcocer-Varela J. J Autoimmun; 2004 Dec 01; 23(4):379-83. PubMed ID: 15571932 [Abstract] [Full Text] [Related]
9. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Garaud S, Le Dantec C, de Mendoza AR, Mageed RA, Youinou P, Renaudineau Y. Ann N Y Acad Sci; 2009 Sep 01; 1173():280-5. PubMed ID: 19758163 [Abstract] [Full Text] [Related]
10. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. Nagafuchi H, Suzuki N, Mizushima Y, Sakane T. J Immunol; 1993 Dec 01; 151(11):6525-34. PubMed ID: 8245483 [Abstract] [Full Text] [Related]
11. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, Szymkowski DE. J Immunol; 2011 Apr 01; 186(7):4223-33. PubMed ID: 21357255 [Abstract] [Full Text] [Related]
12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA. Br J Dermatol; 2004 Apr 01; 150(4):693-700. PubMed ID: 15099365 [Abstract] [Full Text] [Related]
13. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets. Ekşioglu-Demiralp E, Kibaroglu A, Direskeneli H, Yavuz S, Karsli F, Yurdakul S, Yazici H, Akoglu T. J Rheumatol; 1999 Apr 01; 26(4):826-32. PubMed ID: 10229403 [Abstract] [Full Text] [Related]
17. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus. Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S. Arthritis Rheum; 2003 Jun 01; 48(6):1612-21. PubMed ID: 12794829 [Abstract] [Full Text] [Related]
18. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus. Kanda N, Watanabe S. J Allergy Clin Immunol; 2000 Mar 01; 105(3):532-40. PubMed ID: 10719304 [Abstract] [Full Text] [Related]
19. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D. Eur Cytokine Netw; 1993 Mar 01; 4(6):421-7. PubMed ID: 8186374 [Abstract] [Full Text] [Related]
20. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O. Scand J Immunol; 2007 Nov 01; 66(5):584-90. PubMed ID: 17868260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]